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Large studies have established that in patients with acote 
myacadd i&r&on, tbrombolysis reduces mortality (l-5), 
with a red&ion in infarct size (6,7), thus preservbg left 
vellticular flmchn. 
‘Ihe rationale for the use of tbrombolytic agents in the 
management of aa aatte myocardial infarction is derived from 
angbgraphic studies from the early 198@s (8,9), demonstrating 
total coronary obs@action in the early coarse of a myocardial 
infadon in a IarSe percentage of patients. These stodii also 
demonstrated the ability of tbrombolytic agents to reopen the 
infarct-related corouary ves& suppo~ the hypot+e& that 
tbeoccllisioni3mosdydaetoatbrombus. 
lytic agalts, time iaterval between allset of sylnptosls tlllwulba- 
Iytic therapy aad coroaaq aagiagrapby-werp record& in all 
patients, 
(J Am cd cardid 195%;21:1662-8) 
- 
However, despite the use of thrombolytic agents in tbe 
acute phase of a myocardial infarction, tbe infarct-related 
coronary artery remains ooduded io up to 40% of cases (10). 
In the present study, we investigited the hypothesis that ia 
patients treated with tbromholytic agents in tbe early phase of 
a myocardial infarction, the absence of reopeoing of the 
infarct-related coronary vessel may he related to some &nical 
characteristics or to cardiovascul,u risk factors. 
Metknls 
Patieats (Pig. I). Of 368 patients referred to three 
university-*ted coronary care unit8 for ao acote myocardial 
infarch during a l-year period, 295 underwent elective 
cardiac catlieterkatii within 15 days of tbe onset of symptoms 
and were imkded in the present observatbnmi study, which 
wasnotarandomiitrial.Tberemainii73patientsdidoot 
~~~~~~~~e~~~ 
study..these73patienpatients,coronarywasllot 
pelkEedfortbefouowbQreasorE1)deathbltheearIy 
pbaseofthemyoGuui%lfaek(n=25)before~ 
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Admisslml 
Nlrmkrdpatiets 
activated partial thromboplastin time of 90 to i 10 s. On day 5. 
intravenous heparin was replac>d by s&cutaneous heparin 
with the same daily dosage. Aspirin was routinely administered 
within 24 h of admission with an oral daily dose of 250 mg. 
Fv 1. Diagram showing classifreation of patients after hospital 
admission according to cardiac catheterization, smoking status, throm- 
holytic therapy and patent arteries. For convenience, nonsmokers and 
en-smokers were combined. Y = yes; N = no. 
angiography was performed; 2) age r&O years (n = 18); 
3) poor patient condition owing to associated noncardiac 
disease (n = 25); and 4) refusal to give informed consent for 
cardiac catheterization (n = 5). 
In the 2% catbcterhd patients, the specific indications for 
cardiac catheterization were 1) cardiogenic shock (n = 8); 
2) urgent angiography for ongoing angina since the onset of 
the infarction (a = 47); 3) recurrent angina (n = 38); and 
4) systematic angiographic evahration after the infarction (n = 
202). The tint three idications correspond to acute compli- 
cations of the myocardial infarction, leading to earlier cardiac 
catheterization as compared with systematic angiography 
(1.9 2 3.0 days vs. 73 + 2.6 days; p < 0.001). 
In the study group, 166 (56%) of the 295 patients admitted 
within 6 h of the onset of symptoms received iutravenous 
thrombolytic therapy, either streptokinase fn = 851.5 million 
IJ over 60 min) or recombinant tissue-type plasminogen acti- 
vator (&PA) (n = 81,15-mg bolus followed by an iufusiin of 
0.75 mg/trg body weight over 30 min [maximum 50 mg] and 
then au infusion of 0.50 q g/kg over 60 min [maximum 35 mg]). 
‘Ibe allocation of streptokinase or r&PA was not raodomizd 
and was only based on the decision of tbe physician who 
prescrii the treatment. 
The remaining 129 (44%) patients did not receive throm- 
boIytic therapy because of a long delay (>6 h) between the 
onset of symptoms and hospital admisshm (n = 105) or a 
mntraindicaton to thrombo~ytie therapy--primary ventriadar 
l&illation necessitating resuscitation at the onset of the 
i&u&n (n = 4), hitory of gastric uker or diiestive bleed@ 
(n = ll), bistoty of cerebral stroke (n = 5) or a recent 
operation (It = 4). 
In all patients, inttave.nmls lteprin wasintrodocedo?l 
admGorrwithabolusof5&OOIIJfobowedlraamstant 
ittft&Wofl.~XlIU&adjtCxted;IslaeededtorUnbttr4maO 
Variables Assessed 
Cardicr9seuIar risk factors Risk factors for myocardial 
infarction were assessed by a structured questionnaire admin- 
istered by a physician. In total, four risk factors were evahrated 
as discus& next. 
Smoking st~lr~. Based on the information obtained, pa- 
tients were classified as current smokers nonsmoken and 
ex-smokers. Current smokers were patients with a cons~tr- 
tion of tobacco at the time of entry into the hospital, and 
nonsmokers consisted of patients who had never smoked. 
Based on the results of the questionnaire, all ex-smokers had 
abstained from smoking for at least 1 year before admission for 
the current infarction. Lifetime tobacco use was calculated as 
the total number of years of smoking muhiplied by tbe average 
number of cigarettes smoked per day, divided by 20, and 
expressed as pack-years of smoking. 
L&b&s nreU&s. A patient was &hoed as having diabetes 
ifaphyGciandiagno&diabetesbeforeorattbetimeofthe 
current uyrxardial i&rction. 
H)peamh Hypertensioo was delined by history of sev- 
eral blood pressure measurements elevated zither systolii 
(>160 mm Hg) or diastolically (>95 mm Hg). 
!fypmhbM. Hypercbolesterolemia was defined 
by an elevated total serum cho&erol level of 6.2 mmohlitem 
meawed before or at the time of the current myocardial 
infarctinrt (11). 
CIMal e Apart from the questionnaire on 
eardiiar risk factors, eight variables were systematically 
registered in all patientsz 1) age, 2) gender, 3) history of a 
previous myotzdii infarction, 4) location of the present 
myocardial infarction 5) LIsr: of tbromMytic therapy in the 
early phase of the present myocardial infarction. 6) time 
intetvai between the onset of symptoms and w 
therapy (when apptop&ek 7) time interval between tbe onset 
ofsymptomsandcoronaryaagiography,aod8)occurreuceand 
calse of death during tbe hospital stay. 
Cardiac catheterization was per- 
formedbetareeo12hand15daysaftertheometd~ptolm 
(mart [“SD] 5.6 ‘c 3.7 days). 
The awonary attgiosrams were an&ze4l by two experi- 
enced physi&ns who had no knowledge of tbe patieuts’ 
di characteristics and carW&r risk factors the time 
interval between admission and therapy and tbe dinii out- 
~datainchrdedhvewiaMes:1)themun- 
~fcoronaryarteryd&easedvesze~asdefinedbythe 
coroMry Army surgery study (12); 2) the hlfamt-related 
emmary artrq 3) the pateney status of the infaret-reiated 
comuaryartery;4)theresidualstenaGsseverityoftheirtfatct- 
datedvesel,wltcn~e;aud5)titeMfueobtlteIeft 
1664 DE CHILLOLJ ET AL. 
SMOKING AND MYOCARDIAL INFARCTtON 
IACC Vol. 27, Pk.. 7 
June 1996:1662-8 
ing to the area-length method from a cineangiogram in the 30” 
right anterior oblique view. 
The infarct-related Goronaq artery was identified by eiec- 
B on hospital admission, venhiadogmphic con- 
tmction abnormalities and angiographic findings. The patency 
status of the infarct-related coronary artery was evaluated 
using the grading of the Thrombolysis in Myocardial Infarction 
(TIMI) trial (5). A patent vessel was defined by a TIM1 flow 
grade 22. 
statistieol amdysii Patients were classified in two out- 
come groups the patent artery group included patients with c 
patent infarct-related coronary artery, and the occluded artery 
group inch&d patients with an occluded infarct-related cor- 
onary vessel. 
Statistical anaiysh was performed with a BMDP program 
(BMDP Statistical Software, Inc.) on an IBM 486/66 micro- 
computer. 
Univariate logistic regression analysis was Crst performed 
with each variable to determine which ones were sigCfisantIy 
related to tbe presence of a patent vessel. For multivariate 
ana&&, the significant variables were entered in tbe logistic 
regmGonequationinastepwimfashiinbasedontbemaximal 
like- ratio: the tkst variable entered was the one that gave 
the best improvement of the &i-square test, and so on, for the 
following variables, given that all previously entered variables 
remained in the equation. The odds ratio (OR) was estimated 
for each variable found to be correlated with the presence of a 
patent infarct-related coronary artery. 
In ark%* the stat&al inkraction was studied to deter- 
mine the influence of each variable on the di8erem relations 
fotmd to be sign&ant by statistii analysis. 
t3Mimtons variables are expressed as mean value ?T SD. 
f5taahl significance was defined as p < 0.05. 
clfeiral Ma. The study group inchmed 295 patients (239 
men, 56 women [gender ratio 4.21; mean age 59 2 12 years, 
range 27 to 79). Of 295 patie&., 181 (61%) were smokers, 93 
(32%) were nonsmokers aad 21 (7%) were ex-smokers. Ex- 
smokers had quit smoking for 121 + 8.8 years on average 
(range 1 to 35). Average tobacco consumption was 33.4 i: 12.4 
~II&-~IS of smoking (range 10 to 90) in current smokers and 
26.4 +- 11.8 pack$ears of smoking (range 5 to 50) in ex- 
smokexs @ = 0.01). 
A history of hypertension was found in 93 (32%) patients; 
hypch~ie~%rolemia was ptzsent in 103 (35%) patients; and 
diabetes mellitus was present in 23 (8%) patients. Forty (14%) 
patients bad a history of a previous myoca&l infarction. 
Bemuse all of them underwent coronary angiography within 15 
day8 of the iirst it&r&o% the coronary vessel responsible for 
tbecurrenti&rctioncouldbeeasiiydeterminedbyoxnpar@ 
~~angiogtams,-~. 
lRecurrerttmyoca&linfa&onwasameriorin134 
(45%) patients and inferior in 161(55%) patients 
~tberapywasusedintbeaeutephaseofthe 
Ptt 2. Histogram showing frequency of cardiac catheterizations 
versus time interval from onset of myocardial infarction. 
current myocardial infarction in 166 (56%) patients, with a 
mean delay of 3.1 + 1.2 h since the onset of symptoms (range 
0.5 to 6). 
Among the 2% patients, 11 died before hospital discharge 
(cardiogenic shock [n = 51, left free wall rupture [n = 41 and 
postoperative complication after emergency coronary artery 
bypass gratmg [n = 21). 
AIkg@raphie data cQronaly arlgiography was performed 
between 12 h and 15 days after the onset of symptoms (mean 
5.6 2 3.7 days). Figure 2 shows a histogram of the frequency of 
coronary angiograms versus the time interval from the onset of 
the myoeardial infarction. Ninety-three (31.5%) of the 295 
patients underwent cardiac catheterization for cardiienic 
shock (n = 8), persistent chest pain since the onset of 
symptoms (n = 47) or recurrence of clinical myocardial 
ischemia (n = 38). In these 93 patients, the time interval 
between the onset of symptoms and cardiac catheterization 
was shorter (1.9 2 3.0 days vs. 7.3 2 2.6 days; p < 0.001) than 
that in tbe remainmg 202 patients, in whom catheterization 
was performed in the abse*ce of acute compliitions in the 
early course of the infarction. 
The infarct-related vessel was the left anterior descending 
artery in 116 (39%) patients, the circum&x artery in 56 (19%) 
patients and the right coronaty artery in 123 (42%) patients. 
The infarct artery was completely occluded (TIMI flow grade 
0) in 106 (36%) patients. The distriiution of the other TIM1 
flowgradeswilsgra~lin29(1~)patients,grade2in57 
(19%) patients and grade 3 in 103 (35%) patients Single-vessel 
d&ease was found in 143 (48.5%) patients, whereas 83 (28%) 
patients had twc~essel dii and 69 (23.5%) patients had 
three-v-1 dii. 
‘the mean (SD) vahte of the left ventricular ejectjon 
frah was 0.51 t 0.12 (range 0.13 to 0.75). only two facurs 
wtm associated with a higher value for the left ventricubr 
ejeuion fracti~ an infe+iorwall myoemdial infaruii (0.54 r 
0.10 vs. 0.48 2 0.14; p < 0.001) and reopening of the 
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T&k 1. Reiation Between Patency Sthtus of Infarct-Related Vescai 
aad Casdiiascular Risk Factors and Cqulation Variables 
9 (6%) 
39 (242) 
59 (374) 
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31.9 2 126 
42 (26%) 
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0.41 f 0.03 
249266 
infarct-related vessel (0.54 + 0.11 vs. 0.48 t 0.12; p < 0.001). 
The use of thromboiytii therapy was not correlated, per se. 
with the value of the left venbkular ejection fmction (052 rC_ 
0.12 vs. 0.51 1?: 0.12, respectively, for thrombolysis and absence 
of thrombolysis). 
Univariate analysii Ittfarct-nzlated coronary artBy patency 
stahu in relation to car&ascculy risk factors and cwguhriorr 
twit&s. As showu in Table 1, there was no relatiin between 
diabetes mellitus, a history of hypertension or hypercbdester- 
olemia and the patency status of the infarct-related vessel. We 
did not observe any relation between fibrinogen level, platelets 
count or hematocrit and the patency status of the infarct- 
related vessel 
There was a relation between smoking status and patency of 
the infarct-related vessel: The percentage of smokers was 
higher in patients with a patent vessel than patients with an 
oduded vessel. 
The infarct-related artery patency rate was 60% in smokers 
(109 of 181), 45% in nonsmokers (42 of 93) and 43% in 
ex-smokers (9 of 21) (p = 0.03). 
Infrn-R?lQti mIwialy artery pamcy smus in Idaaim to 
clinical data. As showu in Table 2, no correlation was found 
between the patency status of the infarct-related vessel and 
gender, history of previous myocardial infarct& time inter& 
between the onset of symptoms and thrombolytie therapy or 
the time interval between the onset of symptoms and coronary 
WNPPhY* 
The rate of infarct-related vessel reopening was similar in 
patients who received streptolkse (61 of 85 [72%]) as 
compared with those treated with rt-PA (50 of 81(62%]). 
Patients with a patent infarct-related vessel were )rmnges 
than patients with an ccduded ve& (575 + 121 years vs. 
61.3 i: 11.6 years, respectivety; p C O.Ol), and the percentage 
ofantiorwaumyocanliai-wasldgherhthepatent 
artelygroupthanintheocchuMarterygroup(51%~39%, 
respective& p < 0.05). As expected, the percentage of throm- 
bolysis was higher in patients with a patent infarct-related 
vessel as compared with patients with an occluded vessel (69% 
vs 416, respective&, p < 0.01). 
Eleven patients died duriit :bfir hospita! stay. E&h 
omuredmorefqueatIyinthcoc&dedarterygroupthanin 
the patent artery group (7% vs. 1%; p < 0.05). 
Infant-&ted cmvnarJ amy patem? status in t&ion W 
smokingstom and Msis (TafAe 31. In patients who dii 
not receive thrombolytic therapy, the raks of reopening of the 
infarct-related vessel were similar in smokers nonsmokrs and 
ex-smokers (359,424 and 439, respectively). fn nonsmokers 
and ex-~..?rs. ‘L rate of infarct-related artery patency was 
independent of the treatment received (thromboiytic therapy 
or not). Smvkers treated with thrombolytic therapy had a 
higher rate of reopening of tbe infard-related ml 1~ cam- 
pared with smokers not treated with kombo@k agents (OR 
2.2), as well as non- or ex-smokers treated with tbrombdytic 
agents (OR 1.6). Similar results were observed when the. 
Tabk3.Re&ionBetwenSmokingStatus’Ihrombdysisaod 
Patem of the Infarct-Related Vesel 
< o.mt 0.69 
53 la)(m) 19% (zffx I <o.om 
I,? 43 (ZI’F) LWl(Jg’z) 0.99 
3 14(21%) W(l4%) 0.84 
CO.02 0.67 
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delinition of coronary artery patency was defined only as TlMI 
tIowgrade3. 
Eurty~~ninrelnriontosnwkingsranrcandlhrombd 
p& Forty-eight (16.3%) of the 295 patients underwent cal- 
dim catheterization within 24 h of the onset of symptoms. In 
these patientx, the reasons to perform early catheterization 
were 1) persistence of chest pain, although decreased since 
admission, possii related to an absence of reperfusion of the 
infarct-related vessel (II = 41); 2) recurrent chest pain asroci- 
ated with ST segment modifications (n = 2); and 3) cardio 
genic shock (n = 5). 
of these 48 patients, 28 (58%) were current smokers. Of 
these 28,23 (82%) received thrombolytic therapy in the early 
phase of the infarction and the rate of infarct-related artery 
patemy was 70% (16 of 23). Of the remaining 20 nonsmokers, 
12 (60%) were treated with thrombolytic agents and only 2 
(17%) of the 12 subsequently had a patent infarct-related 
vessel (p = 0.009 as compared with smokers). 
Moltnariate at&y&s. Multivariate analysii showed that 
three of the four hmtors iclemiged by univariate analysis were 
independent (thnnnbolysii infarct locatiin and smoking sta- 
tus). The odds ratio of having a patent infarct-related vessel 
was multiplied by 32 3.0 and 1.9, respectively, for the use of 
thmmbolytic therapy, the anterior location of the myocardial 
iufamtion and current conxumption of tobacco on the day of 
admbion. 
When an interaction was identified between any two vari- 
ables in the univariate analysis, this interaction was entered in 
the multivariate analysis model. Hence, the multivariate anal- 
ysis took confounding variables into account to determine the 
independent variabk associated with the patency of the 
infarct-related vessel. 
~n~~~~~~~v~b~~ 
reh&mtosmukiugstatus.TherewasnoreIationbetween 
history of previous myocardi*l infarction, current infarct krca- 
tion, diabetes mellitug history of hypertension or hypercholes- 
terolemia and the smoking status on admiiion. Neither did we 
observe relation hetween fibrinogen level, platelets count or 
hematocrit and the smoking status on admit&i. 
Smokers were younger (56.2 + 11.9 years vs. 64.7 + 10.5 
ycaw p < O.OOl), were predominantly men (85% vs. 68%; p < 
0.001) and received thrombolytic therapy more frequently as 
compared with nonsmokers (60% vs. 46%; p = 0.04). There 
was a relation between the smoking status and the patency 
status of the infarct-related vessek the reopening of the infarct 
vessd being higher in smokers (60% vs. 45% p = OB25). No 
correlation was found between the number of coronary artery 
diseasd vesselr+ left ventricular ejection fradion, percentage 
of residual stenosis and the smoking status 
In- saw&d&y. In the study group, 11(3.7%) of the 
295 patients died during hospimhmtion (7 from cardiogeuic 
~ochand4fromieft~eewalfNpture).Theprsistenceofthe 
occlusion of the h&r&related vessel was associated with a 
higher moltaay (+rwe 2). 
Thepatientsiuourstudyweretakenfromalarger,non- 
selectsdpopulatiouof368 -tive patkm. In this nou- 
selected population, 36 patients died during their hospital stay. 
Four factors were correlated with in-hospital mortality; the 
patients who died were okler (73.1 ? 9.6 years vs. 61.7 + 13.4 
years; p < O.OOl), were predominantly women (47% vs. 21%; 
p < 0.001; OR 2.2), were more likely to have an anterior wall 
infarct location (67% vs. 46%; p = 0.02, OR 2.2) and were 
mainly nonsmokers (61% JS. 27%; p < 0.001; OR 3.6). 
In the nonselected population, the multivariate analysis 
showed that three variables were independently associated 
with m-hospital mortality: absence of current smoking on 
admission, female gender and the anterior wall infarct location 
multiplied the risk of death by 2.4,2.3 and 2.1, respectively. As 
mentioned previously, the multivariate analysis took confound- 
ing variables into account to determine the independent 
variables associated to in-hospital death. 
Discussion 
TbrombuIysis and smukhtg in relation to the patlqeneh 
afthehtfaret-reIatedarteryucduslunintbes&hrgofaeute 
myocu&l lx&c&m. Our study suggests that in patients with 
acute myocardial infarction, thrombolysis is most effective in 
current smokers. One posstble explanation may be that smok- 
ing increases the probability of thrombotic coronary artery 
ecclusion (13-15). In acute myocardial infarction, the coronary 
occlusion consists of both arteriosclerotic tissue and thrombus, 
but their respective importance in a given occlusion is un- 
known Smoking has been associated with platelet activation 
(16) and aggregation (17), coronary vasocons tliction, leduc- 
tion of cornnary gow reserve (18) and increased circtdating 
levels of fibrinogen (19). The pathogenesis of comnary artery 
occlusion may thus be more thrombogenic than atherogenic in 
smokers, whereas in nonsmokers the occlusion may be pre- 
dominantly due to the rupture or uk-eration of the atheromatic 
plaque with the formation of clot rich in platelets, on which 
thrombolytic therapy has little effect. This hypothesis is further 
supported hy our obsezvation that in patients treated with 
thmmbolytic agents, the rate of reopening of the infarct- 
related artery was simiku in ex-smokers and uonsmokets, 
making the role of a diierent atheros&mtic process an 
unlikely explanation. 
Recently, Mueller et al. (20) and Barbash et al. (21) 
reported significantly lower early reinfarction rates after myo- 
cardial infarction in smokers ax compared with non- or ex- 
smokers. This may be consistent 6th our hypothes& in which 
a lower rate of reinfatction is related to a decrease in thrombus 
formationowingtothewidespreaduseofheparinandaspirin 
in the treatment of myocanhal infarction. In smokers, Rivets et 
al.(22)haveshownthattheriskofreinfaraionissignificaoyI 
higher when tobacco comumption is contimred, which sup 
portsthehypo&esisthatathmmbusplaysanimpotQntroIein 
the pathogenesis of myccardial infarctiou in smokers. 
To our knowledge, the only report (23) on the itdhtenee of 
smokiug on the reopen@ of the infarct-related artery re- 
viewedtbedatabaseoftheseeondTrialofEmiuaxeinAcute 
Myocudiy Infiiretktn (TEAM-2) (24b in which au patients 
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received thrombolytic agents and artery patency was assessed 
within 90 to 240 min of the begin&g of thrombolysis infusion. 
Smokershadahigherannplete(TlMIflowgrade3)reopening 
rate of the i!lfara-related vessel as mmpared with mmsmok- 
ets (66% vs. 51%; p = 0.007) (23). In our study, smoker5 
exhibiti a much higher rfqening rate, defined by either 
~Bowgrade3wlyorthecombinationofTIMIflow 
grades 2 and 3.Mormver, non- and ex-smokers did not benelit 
from thrombol@s in terms of coronary artery reopening. 
alldrslpedainfaret-Inour 
rwallinfarctlocationwasanindependent 
factor associated with coronary artery reopening. This finding 
was unexpede-d. !3ome investigators have reported higher 
repetfusim rates in the left anterior descending artery (25) and 
in inferior infarctiom (U), and others found Gnilar patency 
rates among the three arteries (26). Therefore, the reliability of 
ourfindingissuspect.Onecouldhypothesixethatathrombc+ 
genie mechanism was pre&m&nt in Merent arteries from 
one study to another, but this discrepancy may very well be due 
to chance. 
is a major risk factor for mronary 
ntinuance is associated with a 
remadionofthe~withiu2years(27-29)ofquittingsmok- 
ing.Smokingcessationmustbeencouragedtodecaeasethe 
incidenceof~aryarterydiseaseaswellastheincidenceof 
numerous cancers. With the sharp decline in smoking preva- 
lence among adolescents in the 1970s and 1980s (30), we 
shouldexpectadeclineintheincidenceofmyocandialinfarc- 
tion5inthefuture.Ifthisisco&med,theeBicacyofthrom- 
boly&mayakobediluhkmbecausemostmyocan6al 
infarctionswilloccurinnonsmokers.IffUrtherstudiesconfym 
our resulh alternative therapeutic strategies to thrombolysis 
should be evaluated in nommokers. 
Our study was an observational study, 
and some subjects did not receive 
thrombolytic therapy, which co+ inlluence the findii 
We amessed the mrouaxy artery patency with var@le 
delay%Aitaediddelayaswellasrepeatangiograms 
wouldhavenini&edthebii~ofthephysiologic 
variation of the infarct-related artery patency status with time 
(bothforreopeningandreocd&m)intheearlyphaseof 
myoadal iaftim. However, in our study, the time interval 
forcoromuy~co~totheplateauphaseof 
the reapeniq rate of the infarct vessel (lo), so that minimal 
variation should he expected. 
Recent publications (3132) challenge the conventional 
‘&gmathatTIMIflowgrades2and3arefunctiooaltyequal 
with regard to eff& in&c-t vessel reopening. We eooom- 
passedbothTlMItlow~2.uw33defi~apat~tntvesseS 
butfurtheranaly&sbowedasimilarrelatioLbetweensmok- 
in$ thronlbolytictherapya.nd infarct-related aItelypatency, w 
tnanerhowpatencywmdefined. 
of 368 consecutive patients. 73 of whom did not undergo 
coronary angiography. 
Finally, our data on hemostati system variables 
is incomplete; however, our initial aim was not to address thii 
issue spec&a@. No relation was observed between fibrinogen 
level, hematocrit and plate&s and the pateq status of the 
infarct vessel or the smoking status. However, this lack of 
mrrelation may be the result of the small size of our patient 
group, because a correlation has been observed in other 
studies (33). 
(Jadushs. Ourstudyqgeststhatinpatientswithacute 
myocardial infarctioq tbrombolysis is most effective in current 
smokers.Ifmnfirmed,wr ~ki&gSimvcpfadd ini*h 
for the management of aOute myocardial i&r&on. Our 
results indicate that thrombolytic therapy should be pmposed 
to smokers to reopen the infarct-related vessef, whemas other 
strategie$suchasemerpKymronmyangiopksty,shouldbe 
evaluated in further 9wive studies in nonsmokers. 
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